Previous Article | Next Article ![]()
Journal of Clinical Microbiology, September 2002, p. 3381-3390, Vol. 40, No. 9
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.9.3381-3390.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Donald Janssen, and Mark Schrenzel*
Molecular Diagnostics Laboratory, Center for Reproduction of Endangered Species, Zoological Society of San Diego, San Diego, California 92112-0551
Received 2 January 2002/ Returned for modification 9 March 2002/ Accepted 30 June 2002
|
|
|---|
|
|
|---|
In recent years the use of PCR primers for conserved regions of the herpesvirus DNA polymerase gene has facilitated identification of previously unknown viruses (46). Among ruminants, these include bovine lymphotropic herpesvirus (42), caprine herpesvirus 2 (CpHV-2) (4, 19), caprine lymphotropic herpesvirus (CpLHV) (19), and a herpesvirus of unknown origin in white-tailed deer (Odocoileus virginianus) (18). Two of these, CpHV-2 and the herpesvirus found in white-tailed deer, have been provisionally classified as members of the MCF group under Gammaherpesvirinae on the basis of a common antigenic epitope and DNA sequence similarity within the DNA polymerase gene (18, 19). CpHV-2 has been associated with chronic dermatitis and weight loss in sika deer (Cervus nippon) (19), while the virus found in white-tailed deer produced a disease with typical MCF clinical signs but had a prolonged course and chronic histologic lesions (18). These viruses are now included with alcelaphine herpesvirus 1 (AlHV-1) and ovine herpesvirus 2 (OvHV-2) as members of the MCF virus group with known pathogenic potential. AlHV-1, first described and linked to MCF in 1960 (31), can presently be detected by PCR (14, 17, 29) or by serologic methods (17, 20-22) in clinical MCF cases or herd screening. However, unambiguous identification of AlHV-1 may require sequencing of PCR-amplified DNA. OvHV-2 is similarly identifiable by a virus-specific PCR assay (1, 5, 23, 48) and by the same competitive-inhibition enzyme-linked immunosorbent assay (CI-ELISA) that detects antibodies to AlHV-1 (7, 20, 22).
In contrast, two members of the MCF group have not been associated with disease: hippotragine herpesvirus 1 (HiHV-1) (34) and alcelaphine herpesvirus 2 (AlHV-2) (9, 13). The latter has been isolated several times from clinically normal topi or Cape hartebeest, members of the bovid subfamily Alcelaphinae (30, 38, 44, 45), but experimental infections of cattle produce no discernible effects; moreover, inoculation of cattle with AlHV-2 does not elicit antibodies protective against subsequent AlHV-1 challenge (30). AlHV-2 can be detected by AlHV-2-specific PCR as well as by a PCR that will amplify both AlHV-1 and AlHV-2 (14, 17, 29) and by CI-ELISA (19).
We now report evidence that a virus closely related to AlHV-2 caused disease resembling MCF in eight Barbary red deer (Cervus elaphus barbarus) and that the virus may have derived from cohoused, clinically normal Jackson's hartebeest (Alcelaphus buselaphus jacksoni).
|
|
|---|
Serology. Serum samples were submitted to the Washington State University and U.S. Department of Agriculture Animal Research Unit MCF Testing Laboratory in Pullman, Washington, for MCF virus antibody analysis that utilizes a CI-ELISA to detect the presence of antibody (i.e., immunoglobulin M [IgM], IgG, and IgA) to a viral antigen shared by all recognized MCF virus isolates (20, 22).
Necropsy. Complete necropsies were performed on all eight diseased Barbary red deer and eight unaffected animals from groups 1, 2, and 3. Complete sets of tissues were immersion fixed in 10% neutral buffered formalin for histology. Fresh tissue samples of conjunctiva, intestine, kidney, liver, lymph nodes, lung, nasal mucosa, oral mucosa, and spleen were collected from all eight affected Barbary red deer as well as two Sudan Barbary sheep, two mule deer, one Père David's deer, and one stillborn Barbary red deer. Fresh tissue samples of lymph node were taken in 1998 from a Jackson's hartebeest that died from trauma; placenta was taken from a Sudan Barbary sheep that gave birth during the outbreak at the Wild Animal Park. Fresh tissues were frozen at -80°C or were immediately processed for DNA extraction as described below.
Histopathology. Formalin-fixed tissues were routinely processed, sectioned at 5 µm, and stained with hematoxylin and eosin for microscopic evaluation.
DNA and RNA extractions. PBL, solid tissues, and nasal swabs were extracted with a Qiagen Tissue Kit according to the manufacturer's tissue sample protocol, except that the recommended amounts of sample were first placed with the lysis buffer in 1.5-ml screw-cap FastPrep vials containing ceramic beads and were lysed by agitation in a FastPrep shaker (Q-BIOgene, Carlsbad, Calif.) at a speed of 4 to 5.5 for 40 to 60 s, after which the lysate was transferred to a clean Eppendorf tube for continuation of the Qiagen protocol. DNA was also extracted with the Qiagen Tissue Kit as above from frozen tissue culture supernatant of AlHV-1 isolate WC11 (31) from blue wildebeest (Connochaetes taurinus taurinus) and AlHV-2 isolate 840412 (44) obtained from a topi (Damaliscus lunatus jimela). Total RNA was extracted from selected tissues of all eight affected Barbary red deer by using TRIzol (Gibco BRL Life Technologies, Grand Island, N.Y.).
Immunohistochemistry. Five-micromillimeter tissue sections mounted on Platinum slides (Mercedes Medical, Sarasota, Fla.) were deparaffinized, hydrated, washed in phosphate-buffered saline (PBS), blocked with Peroxo-Block (Zymed Laboratories, South San Francisco, Calif.), washed in PBS, and heated in 0.1 M citrate buffer, pH 6.0, at 96°C for 20 min and then allowed to cool to room temperature (RT). Sections were washed in PBS, blocked with avidin-biotin blocking kit (Zymed Laboratories), washed in PBS, blocked with CAS block (Zymed Laboratories), and then treated with a 1:10 dilution of the primary antibody, a custom-made polyclonal rabbit antiserum to psoralen-inactivated AlHV-2 isolate 840412 (44) (LEE BioMolecular, San Diego, Calif.) at RT for 1 h. Control sections were treated with preimmune rabbit serum (LEE BioMolecular) at 1:10 dilution. Sections were washed in PBS and treated with a 1:400 dilution of biotinylated goat anti-rabbit antibody (Zymed Laboratories) for 30 min at RT, washed in PBS, treated with streptavidin-peroxidase (Zymed Laboratories) at 1:400 dilution for 30 min at RT, washed in PBS, and then treated with diaminobenzidine tetrahydrochloride (Vector Laboratories, Burlingame, Calif.) at RT for 5 min and washed in distilled water, counterstained with Gill's hematoxylin, dehydrated, and mounted.
In situ hybridization. Five-micromillimeter sections of selected formalin-fixed, paraffin-embedded tissues on Platinum slides (Mercedes Medical) were deparaffinized, hydrated, treated with trypsin at 37°C for 10 min with Digest-All (Zymed Laboratories), washed in Tris-buffered saline (TBS), heated at 98°C for 12 min in TBS, placed immediately in 4°C TBS, and prehybridized with DIG Easy Hyb Granule solution (Roche Diagnostics Corp., Indianapolis, Ind.) at 42°C for 1 h. A 139-bp cloned and sequenced DNA region from the AlHV-1/AlHV-2 PCR from Barbary red deer was labeled with digoxigenin by using a PCR incorporation method according to the manufacturer's instructions (Roche Diagnostics Corp.) and was used in DIG Easy Hyb Granule solution for hybridization at 42°C for 16 h at 50 pmol of labeled probe per ml of hybridization solution. Slides were washed in 2x SSC (1x SSC is 0.15 M NaCl plus 0.015 M sodium citrate) with 0.1% sodium dodecyl sulfate twice for 5 min at RT followed by two washes in 0.5x SSC with 0.1% sodium dodecyl sulfate at 68°C for 15 min. Slides were blocked in blocking solution (Roche Diagnostics Corp.) for 30 min, washed in TBS, treated with anti-digoxigenin antibody (Roche Diagnostics Corp.) diluted 1:5,000 (150 mU/ml) in TBS for 1 h at RT, washed in TBS, and treated with nitroblue tetrazolium chloride-5-bromo-4-chloro-3-indolyl phosphate, toluidine salt (Roche Diagnostics Corp.) for 10 min, washed in TBS and distilled water, counterstained with Gill's hematoxylin (Surgipath Instrumentation Inc., Richmond, Ill.), and mounted with Crystal Mount (Biomeda Corp., Foster City, Calif.). Duplicate control slides received identical treatment, except no labeled probe was added to the hybridization solution.
Virus isolation. Isolation was attempted by overnight cocultivation of whole blood from one Barbary red deer with clinical signs, using African green monkey kidney (Vero) cells as previously described (10).
PCR. The following 11 PCR assays for potential viral etiologies were performed on DNA or cDNA derived from tissue and nasal swab samples. (i) AlHV-1. PCR specific for a region of AlHV-1 but not of AlHV-2 (16) was done with 20 to 1,000 ng of DNA from tissues or leukocytes. DNA was added to a 25- or 50-µl reaction mixture containing 15 mM Tris (pH 8.0), 50 mM KCl, 2.5 mM MgCl2, and 200 µM each of dATP, dCTP, dGTP, and dTTP. AmpliTaq Gold DNA polymerase (Applied Biosystems, Foster City, Calif.) was used at a final concentration of 0.05 U/µl. Thermal cycling conditions were 9 min at 95°C followed by 35 cycles of 94°C (30 s), 55°C (1 min), and 72°C (1 min), followed by a final extension at 72°C for 10 min. (ii) Deer MCF. PCR specific for the deer MCF agent was used in primary and secondary reactions of either a 25- or 50-µl total volume as previously described (18). (iii) OvHV-2. OvHV-2 virus-specific PCR was used as previously described (1), except that only a single reaction was carried out with the oligomers designed to produce a 422-bp product. The reverse primer (5'-GTCTGGGGTATATGAATCCAGATGGCTCTC-3') was modified slightly at its 5' end to match the reported sequence of the plasmid Bp4a1 (1), kindly supplied by H. W. Reid and used as a positive control. (iv) AlHV-1/AlHV-2. Primers that amplify a homologous region partially within the major capsid protein of AlHV-1 or AlHV-2 were used as previously described (17, 29), with the minor modifications in the reaction and cycling conditions listed above for the AlHV-1 PCR. (v) Barbary red deer AlHV-1/AlHV-2. Primers (forward, 5'-TTTATTGAAGAAGTGGCTC-3'; reverse, 5'-CCATTTTGTTTTGTCCTG-3') that were designed to the Barbary red deer virus sequences generated by the AlHV-1/AlHV-2 PCR described above were used for nested reamplification of all samples that were negative with the AlHV-1/AlHV-2 PCR. One microliter of PCR product from the AlHV-1/AlHV-2 PCR was used as template. Thermal cycling conditions for the inner primer pair were 6 min at 95°C followed by 30 cycles of 94°C (30 s), 47°C (30 s), and 72°C (20 s), followed by a final extension at 72°C for 7 min. (vi) Herpesviridae DNA polymerase. PCR using degenerate primers that target consensus regions of herpesvirus DNA polymerase genes for amplification of all herpesviruses was conducted as previously described (18, 42, 46). (vii and viii) Bovine herpesvirus 1 (BHV-1) and bovine herpesvirus 5 (BHV-5). PCR on DNA from selected tissues for detection of BHV-1 and BHV-5 was done as described previously (41). (ix to xi) Bovine viral diarrhea virus (BVDV), vesicular stomatitis virus (VSV), and foot-and-mouth disease virus (FMDV). Reverse transcriptase-PCR for BVDV, VSV, and FMDV was done on total RNA from selected tissues as described previously (39, 40, 47).
DNA manipulation and sequencing. PCR products of the expected size from representative tissues and cases were purified and either direct sequenced or cloned by using the TOPO TA Cloning Kit (Invitrogen). Sequencing reactions were performed by using the CEQ DTCS (dye terminator cycle sequencing) Quick-Start Kit (Beckman Coulter, Fullerton, Calif.). Sequences were acquired by using a CEQ 2000XL capillary sequencer (Beckman Coulter). Sequence analysis and alignments were conducted by using the MacVector v. 7.0 and AssemblyLIGN v. 1.0.9 software packages (Accelrys, San Diego, Calif.). Sequence data were compared to the GenBank database with the basic local alignment search tool.
Southern hybridization and detection. Southern blotting of all PCR products was performed by capillary transfer (43) or by use of a PosiBlot pressure apparatus (Stratagene, La Jolla, Calif.) with positively charged nylon membranes (Amersham Pharmacia Biotech, Piscataway, N.J., or Millipore, Bedford, Mass.). DNA was fixed to the membrane by using a Stratalinker (Stratagene). DNA probes were generated by labeling with digoxigenin by using either the DIG Oligonucleotide 3'-End Labeling Kit or the PCR DIG Probe Synthesis Kit (Roche Molecular Biochemicals, Indianapolis, Ind.) and specific oligomers or PCR-amplified sequence from control plasmids or plasmids containing cloned and sequenced initial amplification products. Hybridization and detection were performed with reagents of the DIG High Prime DNA Labeling and Detection Kit (Roche Molecular Biochemicals) and exposure of the treated blots to Kodak X-Omat LS X-ray film (Eastman Kodak Co., Rochester, N.Y.).
Nucleotide sequence accession numbers. The nucleotide sequences obtained in this study from Barbary red deer and Jackson's hartebeest were deposited in GenBank with accession numbers AY092763 (partial major capsid protein sequence) and AY092762 (partial polymerase sequence). The sequence from AlHV-1/AlHV-2 PCR on topi AlHV-2 isolate 840412 was also deposited in GenBank with accession number AY125489.
|
|
|---|
Serum samples were tested by CI-ELISA that detects the presence of immunoglobulins (i.e., IgM, IgG, and IgA) specific for an antigen shared by all MCF viruses isolated to date (20, 22). Serum samples taken just prior to euthanasia from six of seven disease-affected Barbary red deer were positive by the CI-ELISA. Three of these positive animals had been seronegative prior to the outbreak, and one was seropositive. Of other group 1 animals, three out of three Jackson's hartebeest and one scimitar-horned oryx were seropositive, while a Soemmerring's gazelle, a southeastern crowned duiker, and a clinically normal Barbary red deer were seronegative. Of group 2 animals, three out of three Sudan Barbary sheep were negative. Seven of the eight clinically normal Barbary red deer located at the San Diego Zoo (group 3) were seronegative. These results are summarized in Table 1.
|
View this table: [in a new window] |
TABLE 1. Serology results for MCF antibodies by CI-ELISA
|
Microscopically, lesions in the skin, oral cavity, and conjunctiva consisted of erosions and ulcers with infiltrates of neutrophils and lymphocytes. Lymphocytes predominated, and infiltrates were most dense in the superficial dermis and submucosa with extension into the overlying epithelium. Some vessels had perivascular inflammatory cells. Lymphoid infiltrates were present in some bronchi and bronchioles and in the trachea. Lymph node sinuses were filled with neutrophils. Vasculitis was not seen in any cases.
Immunohistochemistry with polyclonal anti-AlHV-2 serum and in situ hybridization with a Barbary red deer virus-specific probe demonstrated virus within the cytoplasm and nuclei of occasional oral submucosal salivary gland cells located beneath areas of ulceration and inflammation (Fig. 1). No staining was seen within lesions or in unaffected tissues.
![]() View larger version (132K): [in a new window] |
FIG. 1. (A and B) Photomicrographs of immunohistochemistry for AlHV-2 demonstrating positive staining in buccal salivary gland cells (A) and no staining in negative control (B). Diaminobenzidine tetrahydrochloride with Gill's hematoxylin counterstain, bar = 50 µm. (C and D) In situ hybridization with an AlHV-2-like viral PCR probe from Barbary red deer with a similar pattern of virus detection in submucosal salivary glands (C) and lack of staining in negative control (D). Nitroblue tetrazolium chloride-5-bromo-4-chloro-3-indolyl phosphate was used with Gill's hematoxylin counterstain. Bar = 50 µm.
|
|
View this table: [in a new window] |
TABLE 2. PCR assays for MCF viruses performed on samples from affected Barbary red deer and unaffected animalsa
|
![]() View larger version (45K): [in a new window] |
FIG. 2. Alignment of homologous DNA sequences from the AlHV-1/AlHV-2 PCR for Barbary red deer, Jackson's hartebeest, topi AlHV-2, and previously characterized MCF viruses. Identical nucleotides in the majority of aligned sequences for a given position are enclosed in a box. Sequence identity between the Barbary red deer virus amplimers and other MCF viruses is shown in bold adjacent to the ends of the sequences. The GenBank accession number (and reference) for AlHV-1 is AF005370 (6). The source of the AlHV-2 isolate was topi (Damaliscus lunatus jimela), isolate 840412 (44).
|
![]() View larger version (83K): [in a new window] |
FIG. 3. Ethidium bromide-stained agarose gel (A) and film exposure of Southern blot hybridization (B) of Barbary red deer AlHV-1/AlHV-2 PCR for selected unaffected animals, including Jackson's hartebeest. Lanes 1 and 20, AlHV-1 isolate WC11 (31) from blue wildebeest; lanes 2, 9, and 12, 100-bp ladder; lane 3, Jackson's hartebeest 697068 PBL sampled in October 2001; lane 4, Jackson's hartebeest 697068 nasal swabs sampled in October 2001; lane 5, Jackson's hartebeest 697068 PBL sampled in January 2002; lane 6, Jackson's hartebeest 697068 nasal swabs sampled in January 2002; lane 7, Jackson's hartebeest 601119 PBL; lane 8, Jackson's hartebeest 601119 nasal swabs; lane 10, affected Barbary red deer 696250 nasal swabs; lane 11, Jackson's hartebeest 697064 lymph node sampled in October 1998; lane 13, Ankole PBL; lane 14, scimitar-horned oryx PBL; lanes 15 to 18, mule deer intestine, liver, lymph node, and spleen, respectively; lane 19, no-DNA negative control.
|
![]() View larger version (86K): [in a new window] |
FIG. 4. Alignment of homologous DNA sequences for the Herpesviridae DNA polymerase PCR from Barbary red deer, Jackson's hartebeest, and known MCF viruses. Identical nucleotides in the majority of aligned sequences for a given position are enclosed in a box. Sequence identity between the Barbary red deer virus amplimers and other MCF viruses is shown in bold adjacent to the ends of the sequences. GenBank database numbers (and references) for AlHV-1, AlHV-2, OvHV-2, and the deer MCF virus are AF005370 (6), AF275942 (19), AF031812 (42), and AF181468 (18), respectively.
|
![]() View larger version (31K): [in a new window] |
FIG. 5. Alignment of predicted amino acid sequences from the Herpesviridae DNA polymerase PCR from Barbary red deer, Jackson's hartebeest, and known MCF viruses. Similar residues between aligned sequences for a given position are enclosed in a box. Identity between the Barbary red deer virus predicted amino acid sequence and other MCF viruses is shown in bold adjacent to the ends of the sequences. GenBank numbers (and references) for AlHV-1, AlHV-2, OvHV-2, and the deer MCF virus are AF005370 (6), AF275942 (19), AF031812 (42), and AF181468 (18), respectively.
|
Virus isolation attempts from affected Barbary red deer were assessed by microscopic inspection of cell cultures and PCR and were determined to be unsuccessful after 20 days in culture.
|
|
|---|
Data from PCR and serology identified the novel AlHV-2-like virus as the etiology of disease in the Barbary red deer. Other viruses which can cause disease similar to MCF, such as BHV-1, BHV-5, BVDV, VSV, and FMDV, were excluded by PCR. The possibility of a different MCF virus causing the outbreak was also eliminated by extensive sequencing of positive amplicons from the two broader-specificity PCR assays (AlHV-1/AlHV-2 and Herpesviridae DNA polymerase) and negative results of specific PCR assays for AlHV-1, deer MCF, and OvHV-2. The demonstration of viremia in seven out of seven Barbary red deer with MCF and lack of virus infection in every Barbary red deer without MCF, along with the marked contrast in MCF seroreactivity between diseased and healthy Barbary red deer, strongly implicate the AlHV-2-like virus as the primary cause of the outbreak.
AlHV-2 has been isolated from two species of topi (Damaliscus korrigum and Damaliscus lunatus jimela) and a Cape hartebeest (Alcelaphus buselaphus caama) (30, 44, 45). None of these animals had clinical disease. In our study, both immunohistochemistry and molecular data indicated that the virus present in Barbary red deer was closely related to AlHV-2. Positive staining on immunohistochemistry provided evidence that the etiologic agent in the Barbary red deer possesses structural proteins similar to those of AlHV-2, as the primary antibody used in staining was from rabbits immunized with topi AlHV-2 isolate 840412 (44) purified from cell culture supernatant fluid. This polyclonal serum was previously shown by indirect immunofluorescence to bind to AlHV-2-infected cultured cells but not to cells infected with AlHV-1 (R. S. Lahijani, R. B. Klieforth, B. S. Seal, S. M. Sutton, and W. P. Heuschele, 43rd Annual Conference of the Wildlife Disease Association, abstr. 91, 1994). DNA sequences from the PCR. for AlHV-1/AlHV-2 and Herpesviridae DNA polymerase were clearly more similar to AlHV-2 than to any other MCF virus. In regard to the nucleotide differences of 5 to 6% between the red deer virus and AlHV-2 isolate 840412 (44), we cannot infer from this limited information whether the agent identified in these MCF cases is a strain of AlHV-2 or a closely related, novel virus species. Nucleotide sequence differences between two types of Epstein-Barr virus (EBV) occur at a rate of about 1 to 2% over most of the genome, but four EBV genes show nonsynonymous nucleotide substitutions resulting in differences from 8 to 29% between strains (27). The paucity of sequence information from isolates of any MCF virus precludes obtaining a range of normal strain variability within this group. If the Barbary red deer virus is indeed a strain of AlHV-2, this is particularly intriguing because AlHV-2 has not previously been implicated in clinical disease resembling MCF in any ruminants.
MCF has been previously recognized in red deer (Cervus elaphus) in Scotland and New Zealand. The source of the virus in Scotland was not determined, but sheep were suspected. On the basis of the severity of disease, red deer were believed to be especially sensitive to MCF (35). In that report, lymphoproliferative changes were extensive but viral particles were not seen ultrastructurally in any of the lesions. Authors of another study of naturally occurring and experimentally induced MCF in cattle described lack of evidence in the literature for immunohistochemical association between the virus and lesion sites (25) and also found no ultrastructural evidence of virus in vascular or systemic epithelial lesions of the cases they examined (25, 26). Electron microscopy was not attempted for our study. However, immunohistochemistry demonstrated the presence of occasional positive cells in buccal salivary glands adjacent to oral lesions, though not in the lesions themselves. In situ hybridization was also successful, producing a similar pattern of staining in the same tissue. It cannot be determined with certainty whether these results indicate productive infection with release of virus, but salivary glands as sites of MCF virus replication would provide a means for efficient excretion into the environment. Other researchers also used in situ hybridization to demonstrate viral infection of pulmonary alveolar cells of wildebeest (Connochaetes spp.) calves (28), suggesting another possible site for replication and a mechanism for excretion by aerosolization.
The CI-ELISA test proved valuable in the Barbary red deer outbreak not only for corroborating an MCF virus as the etiology but also for helping identify possible reservoirs of the virus. Among our cases there was evidence for seroconversion in three Barbary red deer. One red deer that developed disease was seropositive for two or more years prior to the outbreak. It is possible that this animal suffered from recrudescence of a latent infection with the AlHV-2-like virus and then spread the virus to immunologically naïve red deer. Apparent latency and recrudescence of MCF have been documented for Formosan sika deer (12). Alternatively, seroreactivity in this red deer may have been to a different MCF virus, such as AlHV-1 or OvHV-2, and the AlHV-2-like virus causing the outbreak may have arisen from another species within or adjacent to the enclosure.
The Barbary red deer that developed disease in our study had direct or indirect contact with seven other species of ruminants, any of which may have been primary or intermediate reservoirs for the virus that caused the outbreak. Of these animals, only a scimitar-horned oryx and Jackson's hartebeest were seropositive for MCF virus. AlHV-1 seroreactivity has been reported for several species of oryx that were clinically normal (37, 44), but AlHV-2 has never been described in oryx. The scimitar-horned oryx in our study was negative by PCR of blood for all MCF viruses. Among the other animals that had contact with Barbary red deer, only mule deer have been reported with MCF (35, 36). The mule deer tested in our study lacked lesions of MCF and were negative by PCR for numerous tissues but, along with the oryx, still cannot be completely excluded as possible intermediate reservoirs. Coke's and Cape hartebeest have long been recognized as carriers of AlHV-1 or AlHV-2 and have been implicated in natural transmission of virus to other ruminants (9, 37, 44). Our study is the first report of an MCF virus in Jackson's hartebeest. The confirmation of identical AlHV-1/AlHV-2 and Herpesviridae DNA polymerase sequences in Barbary red deer and seropositive, cohoused Jackson's hartebeest points toward the hartebeest as a possible primary reservoir for the virus precipitating the epizootic. It is especially noteworthy that both of the hartebeest tested were viremic and that PCR was positive on nasal swabs, suggesting that virus was being shed in nasal excretions. Barbary red deer are one of only two deer subspecies native to Africa, but they have not shared ranges with hartebeest for several hundred years (8, 32). It is possible that the lack of contact between modern Barbary red deer and hartebeest resulted in an increased vulnerability of the deer to MCF viruses indigenous to hartebeest, such as the AlHV-2-like virus in this outbreak.
The failure to isolate a virus from Barbary red deer is not surprising. It may be that the Vero cells were not permissive for infection by this particular MCF variant or that too much time elapsed between blood collection and inoculation of cell culture flasks. It has been observed for MCF viruses in general that tissues must be collected within 1 to 2 h of death, and attempts at virus isolation must be begun immediately as the viruses are rapidly inactivated in tissues after death (13). This appears to be a consequence of MCF viruses typically being highly cell associated during in vivo infections (11).
Li et al. (19) have observed that the traditional view of MCF as an "acute highly lethal disease with a short course . . . and a fairly characteristic set of signs and lesions" is rapidly giving way to one of a wider range of disease presentations caused by a greater number of viruses whose common features are a clustering of DNA sequence similarities disjunct from other gammaherpesviruses and a specific antigenic epitope defined by the monoclonal antibody used in the CI-ELISA. In the present cases there is evidence of antigenic similarity to other MCF viruses by CI-ELISA and immunohistochemistry and of DNA sequence similarity to other viruses in the MCF group. The close resemblance to AlHV-2 sequence, in particular, is unique among the viruses associated with MCF-like disease in ruminants to date. Comparison of additional nucleotide and derived amino acid sequences by phylogenetic analysis will provide more information on the relatedness of the etiologic agent in this outbreak to AlHV-2 and other gammaherpesviruses.
We thank the Beckman Coulter Corporation for donation of the automated capillary DNA sequencer and high-speed centrifuge used in these studies.
This work is dedicated to the memory of Werner Heuschele. ![]()
Present address: Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California, Davis, CA 95616. ![]()
|
|
|---|
-Herpesvirinae. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356:421-435.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»